用户名: 密码: 验证码:
仙鹤草红外光谱分析及其鞣质抗肿瘤作用研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
仙鹤草(Agrimonia Pilosa Ledeb)为蔷薇科多年生草本植物龙芽草的全草。传统主要用于治疗各种出血证,现代研究证明,仙鹤草还有抗肿瘤、降血糖、升压等作用。仙鹤草中鞣质类成分含量丰富,且鞣质的研究也日益受到国内外科研工作者的重视。本文首次采用傅立叶变换红外光谱法(FT-IR)对仙鹤草进行分析,对其鞣质成分进行体内、体外抗肿瘤作用研究,并初步探讨其作用机理。
     红外光谱研究结果表明,通过帽儿山仙鹤草主体成分红外图谱对比分析可知,仙鹤草在1659 cm-1、1569 cm-1、1168 cm-1和989 cm-1处有4个鞣质特征峰,并且在1643cm-1、1512 cm-1和1470cm-1波长附近也存在鞣质特征峰,说明仙鹤草中含有鞣质成分;通过红外光谱的三级鉴定可知,七种产地仙鹤草丙酮提取物乙酸乙酯和正丁醇层均含有鞣质成分,且鞣质量不同,并通过对其原药材和提取物的分析可将七种产地的仙鹤草区分开;通过对不同提取物的乙酸乙酯层和正丁醇层一维红外光谱和二阶导数红外光谱分析可知,不同提取物的乙酸乙酯层和正丁醇层中均含有鞣质成分,但鞣质量不同,只有以丙酮作为提取溶剂时才能充分提取出鞣质成分;通过乙酸乙酯层和正丁醇层精制前后的一维红外光谱和二阶导数红外光谱与单宁酸标准图谱对比分析可知,经过精制制备后,可以不同程度的提高样品的纯度;采用经干酪素法测定精制制备后的仙鹤草丙酮提取物乙酸乙酯层和正丁醇层的平均鞣质含量分别为19.91%和14.87%。所以,傅立叶变换红外光谱法作为鉴别不同产地的仙鹤草是一种有效的手段,且为仙鹤草利用红外光谱创建指纹图谱打下了基础。
     体内抗肿瘤实验结果表明,乙酸乙酯层和正丁醇层均可以抑制S180小鼠实体瘤的生长,与阴性组相比,各给药组具有显著性差异(P<0.05),均表现出良好的抑瘤作用,200 mg/kg的乙酸乙酯层的抑瘤率为50.44%,250mg/kg的正丁醇层的抑瘤率为57.52%;乙酸乙酯层和正丁醇层各剂量组均能不同程度的升高S180小鼠胸腺指数和脾指数,对荷瘤小鼠两大免疫器官具有良好的保护作用;仙鹤草丙酮提取物乙酸乙酯层和正丁醇层可提高抗氧化酶SOD、CAT和GSH活力,降低脂质过氧化产物MDA的含量,说明乙酸乙酯层和正丁醇层能够明显的提高荷瘤小鼠抗氧化系统的功能,抑制脂质过氧化,清除体内过剩的氧自由基,进而发挥抗肿瘤作用,且乙酸乙酯层的作用优于正丁醇层,仙鹤草的抗肿瘤作用可能通过抗氧化作用实现的,这也可能是其体内抗肿瘤作用机理之一。
     由体外抗肿瘤实验结果可知,乙酸乙酯层和正丁醇层均可显著抑制BEL-7402细胞和HepG2细胞的生长,并随着药物浓度的增大而增强,作用较明显。乙酸乙酯层对BEL-7402细胞的IC50为89.28 gg/mL,对HepG2细胞的IC50为127.85 gg/mL,正丁醇层对BEL-7402细胞的IC50为107.54μg/mL,对HepG2细胞的IC50为234.41 gg/mL,乙酸乙酯层的作用明显强于正丁醇层;通过流式细胞仪(FCM)进一步检测可知,乙酸乙酯层和正丁醇层均能诱导BEL-7402细胞和HepG2细胞发生细胞凋亡,且作用较明显;通过激光共聚焦显微镜检测可知,不同浓度的乙酸乙酯层和正丁醇层作用于BEL-7402细胞和HepG2细胞48 h后,肿瘤细胞明显减少,均不同程度的出现细胞核裂解,出现较明显的凋亡形态,且有明显的绿色荧光,表明肿瘤细胞内游离Ca2+水平升高;不同浓度的乙酸乙酯层和正丁醇层作用于BEL-7402细胞和HepG2细胞48 h后,细胞内活性氧(ROS)均随给药剂量的增加而增加,与空白组相比,均具有显著性差异(P<0.05)。所以,肿瘤细胞内游离Ca2+水平超载和活性氧水平的升高可能诱导BEL-7402细胞和HepG2细胞发生细胞凋亡,这也许是其体外抗肿瘤作用的机理之一。
     本文首次采用FT-IR对仙鹤草进行了分析,为其利用红外光谱创建指纹图谱奠定基础,并能确定仙鹤草丙酮提取物乙酸乙酯层和正丁醇层中均含有一定量的鞣质成分,且鞣质含量不尽相同。通过药理实验可确定仙鹤草中鞣质成分具有抗肿瘤作用,其作用机理可能是通过增强抗氧化系统功能和诱导肿瘤细胞凋亡来实现的。
Agrimony (Agrimonia Pilosa Ledeb) is the Rosaceae perennial herb agrimony of the whole plant. The traditional major treatment is for the kinds of bleeding. The modern researches show that agrimony was used for the anti-tumor, reducing blood glucose, boosting pressure and so on. The tannin is abundant in the agrimony, and the study on tannin is thought more and more important in internal and abroad scientific researchers day by day. In this paper, Fourier Transform Infrared Spectroscopy (FT-IR) was the fist time used for the analysis of agrimony, and investigating its tannin components of anti-tumor effect in vitro and vivo and exploring its mechanisms.
     The results of FT-IR showed through the FT-IR analysis the Mao ershan agrimony had the four tannin characteristic peaks in 1659 cm-1,1569 cm-1,1168 cm-1 and 989 cm-1, and there were tannin characteristic peak near the 1643 cm-1,1512 cm-1 and 1470 cm-1. The results illustrated the agrimony had tannin components. Through the analysis of the multi-steps infrared maro-fingerprint method showed that the ethyl acetate and the n-butanol abstraction from the acetone extraction of seven habitats agrimony contained a certain amount of tannin component and the content was different. We could distinguish them by using the origin Chinese medicinal materials and the extracts of the agrimony from different habitats. Through the analysis of the one-dimensional infrared spectroscopy and the second derivative infrared spectroscopy of the ethyl acetate layer and the n-butanol layer of the different extractives, the ethyl acetate layer and the n-butanol layer of the different extractives both had the tannin component and the content was different. The tannin was extracted adequately only by using the acetone. The comparative analysis between the ethyl acetate layer, the n-butanol layer and tannin through one-dimensional infrared spectroscopy and second-derivative infrared spectra. After the purification, the purity of the ethyl acetate layer and the n-butanol layer were raised on the different degree. The average tannin contents were 19.91% and 14.87% of the ethyl acetate and the n-butanol layer of agrimony acetone extracts by casein method. So, Fourier Transform Infrared Spectroscopy was the useful method on the identification of different habitats agrimony. And this was the foundation of the finger print of agrimony by FT-IR.
     The vivo anti-tumor results showed that the ethyl acetate layer and the n-butanol layer could inhibit the growth of S180 entity-tumor mice, as compared with the control group, the administration groups were significant difference(P<0.05). The inhibitory rate was 50.44% by 200 mg/kg of the ethyl acetate layer, and the inhibitory rate was 57.52% by 250 mg/kg of the n-butanol layer. Both the ethyl acetate layer and the n-butanol layer increased the thymus index and spleen index of S180 entity-tumor mice in different level, and had a good protective effect for the two immune organs in entity-tumor mice. The ethyl acetate and the n-butanol layer of agrimony acetone extracts enhanced the antioxidant enzymes SOD, CAT and GSH activity, reduced lipid peroxidation MDA content.So the ethyl acetate extract layer and the n-butanol layer significantly increased the antioxidant functions of the system of the entity-tumor mice, inhibited lipid peroxidation, cleaned the of excess oxygen free radicals, and played an anti-tumor effect, which might be the one of the mechanisms in vitro anti-tumor effect.
     Through the vitro anti-tumor results, we could see that the ethyl acetate layer and the n-butanol layer both inhibited the growth of BEL-7402 cells and HepG2 cells significantly, and the effect was enhanced by the increasing of concentration apparently. The BEL-7402 cell's IC50 was 89.28μg/mL and the HepG2 cell's IC50 was 127.85μg/mL of the ethyl acetate layer; The BEL-7402 cell's IC50 was 107.54μg/mL and the HepG2 cells's IC50 was 234.41μg/mL of the n-butanol layer.The ethyl acetate layer was better obviously than the n-butanol layer. The ethyl acetate layer and the n-butanol layer could induce the BEL-7402 cells and the HepG2 cells apoptosis by flow cytometry (FCM) further, and had a good effect. Through the laser confocal microscopy, we saw that the tumor cells significantly reduced by different concentrations of the ethyl acetate layer and the n-butanol layer on the BEL-7402 cells and HepG2 cells after 48 h, and there were nuclear cracking, apparent apoptosis shape, and there was a clear green fluorescence. These showed that the overloading of tumor cells elevated levels of intracellular free Ca2+ might be increased. The different concentrations of the ethyl acetate layer and the n-butanol layer effected on the BEL-7402 cells and HepG2 cells after 48 h, the intracellular reactive oxygen species (ROS) were increased with the concentration increased by FCM. As compared with the control group, there was significant differences (P<0.05). Therefore, the increasing of tumor cells intracellular free Ca2+ and the ROS might induce the tumor cells apoptosis, this might be the one of the mechanisms in vivo anti-tumor effect.
     In summary, FT-IR was the fist time used for the analysis of agrimony and created the foundation of the agrimony's finger print, and there were tannin component in the ethyl acetate and the n-butanol layer of agrimony acetone extracts, but the content was differnt. Through the pharmacology researches determined that the tannins of agrimony had anti-cancer effect, and its mechanisms might be enhancing the antioxidant functions and inducing the tumor apoptosis.
引文
[1]GELDERBLOM H, SALAZAR R, VERWEIJ J, et al. Phase Ⅰ pharmacological and bioavailability study of oral flomote can (BN80915), a novel Ering modified camptothecin analogue in adults with solid tumors. Clin Cancer Res,2003,9(11): 4101-4107
    [2]HANNA N, SHEPHERD FA, FOSSELLA FV, et al. Randomized phase Ⅲ trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol,2004,22(9):1589-1597
    [3]KELLAND LR. An update on satraplatin:the first orally availab platinum anticancer drug. Expert Opin Investig Drug,2000,9(6):1373-1382
    [4]DUFFAUD F, BLAY JY. Gastrointestinal stromal tumors biology and treatment. Oncology,2003,65(3):187-197
    [5]VENET M, END M, ANGIBAUD P. Famesyl protein transferaseinhibitor ZARNESTRA R115777-history of a discovery. Curr Top Med Chem,2003, (10): 1095-1102
    [6]Van CUTSEM E, van de VELDE H, KARASEK P, et al. Phase Ⅲ trial of gemcitabine plus tipifamib compared with gemcitabine plusplacebo in advanced pancreatic cancer. J Clin Oncol 2004,22(8):1430-1438
    [7]TOPPMEYER DL, GOUNDER M, MUCH I, et al. A phase Ⅰ and pharmacologic study of the combination of marimastat and paclitaxel in patients with advanced malignancy. Med Sci Monit,2003,9(8):PI 99-PI 104
    [8]TEODORI E, DEI, QUIDU P, et al. Design, synthesis and in vitro activity of catamphiphilic reverters of multidrug resistance discovery of a selective, highly efficacious chemosensitizer with potency in the nanomolar range. J Med Chem,1999, 42 (9):1687-1697
    [9]于婺,宫淑秋,衣永梅.天然药物在肿瘤防治中的作用.中国药物与临床,2006,6(6):443-444
    [10]国安弘基,韩少良.癌症治疗的最新进展.日本医学介绍,2000,21(7):317-319
    [11]刘燕,林瑞超,李波.云芝多糖抗肿瘤作用研究进展.中成药,2008,23(10):755-757
    [12]赵鹏,刘明,董新舒,等.苹果提取物抑制大肠癌生长的实验研究.中华外科杂志,2004,42(15):958-959
    [13]李春峰.植物化学物质抗肿瘤作用的研究进展.实用肿瘤学杂志,2009,19(5):393-396
    [14]Adom K K, Sorrells M E. Liu R H. Phytochemicals and antioxidantactivoty of wheat varieties.Agric Food Chem,2003,51:7825-7834
    [15]李电东,明秀英,甄水苏,等.茯苓素对抗癌药的增效作用.中国抗生素杂志,1990,15(1):63-64
    [16]迟文,黄国良,郭凌燕,等.杨梅多酚对小鼠在放化疗中白细胞减少的影响.中成药,2001,23(1):50-51
    [17]曹世龙.肿瘤学新理论与新技术.上海:上海科技教育出版社,1997,267
    [18]Negoescu A, Guillermet C, Lorimier P, et al. Importance of DNA fragmentation in apoptosis with regard to TUNEL specificity. Biomed Pharmacother,1998,52 (6): 252-258
    [19]Mirakian R, Nye K, Palazzo FF, et al. Methods for detecting apoptosis in thyroid disease. J Immunol Methods,2002,265:161-175
    [20]Afford S, Randhawa S. Apoptosis. J Clin Pathol MolPathol,2000,53:55-63
    [21]郑晓亮,刘雪莉,钱伯初.植物提取物诱导肿瘤细胞凋亡机制研究进展.中国药理学通报,2004,20(11):1201-1205
    [22]Cappelletti V, Fioravanti L, Miodini P, et al. Genistein blocksbreast cancer cells in the G2/M phase of the cell cycle. J Cell Biochem,2000,79(4):549-600
    [23]郑丽端,童强松,吴翠环,等.姜黄素诱导卵巢癌细胞株A2780细胞周期阻滞和凋亡.华中科技大学学报(医学版),2003,32(2):209-214
    [24]唐尧,宋毅,徐珽,等.天然药物诱导肿瘤细胞凋亡的研究进展.中国医院药学杂志,2006,26(4):461-464
    [25]何金涛,周清华,袁淑兰,等.丹参酮诱导人肺癌细胞凋亡及其分子机理.中国肺癌杂志,2002,5(4):257-259
    [26]洪卫,张沂平.中药诱导肿瘤细胞凋亡研究进展.浙江中西医结合杂志,2009,]9(7):451-454
    [27]Yu SY, Choi SH, Park W B.Korean mislletoe lectin-induced apopLosis in hepatocarcincma cells is associated with inhibition of tel cmerase via mitochondrial controlled pathway independent of p53. Arch Pham Res,2002,25(1):93-101
    [28]Ark D I, Lee JH, Moon SK, et al. Induction of apoptosis and inhibition of telcmerase activity by aqueous extract from Platycodon grandiflorum in human lung carcincma cells. Phamacol Res,2005,51(5):437-443
    [29]Mukherjee N, Chakraborty S, Ghosh U, et al. Curcum in induced apoptosis in human leukemia cell HL-60 is associated with inhibition of telcmerase activity. Mol CLL Biochem,2007,297(1-2):31-39
    [30]Chakraborty S, Ghosh U, Bhattacharyya NP, et al. Inhibition of telcmerase activity and linduction of apoptosis by curcum in K-562 cells. Muta Res,2006,596(1-2):81-90
    [31]聂绍荃,袁晓颖,杨逢建.黑龙江植物资源志.第1版.哈尔滨:东北林业大学出版社,2003,12:343
    [32]沈阳药学院,辽宁省药物研究所,中国医科院药物研究所.鹤草酚的结构研究.化学学 报,1977,35(1,2):87-96
    [33]裴月湖,李铣,朱延儒.仙鹤草根芽中化学成分的研究.药学学报,1989,24(6):431-437
    [34]Horikawa K. Moderate inhibition of mutagenicity and carcinogenicity of benzo[a] pyrene,1,6-dinitropyrene and 3,9-dinitrofluoranthene by Chinese medicinal herbs. Mutagenesis,1994,9(6):52
    [35]李良泉,郑亚平,路佩琳,等.仙鹤草有效成分的研究.化学学报,1978,36(1):43-48
    [36]Kouno isao Baba naosuke. Triterpenoide form Agrimoniapilosa. Phytochemistry.1988, 27(1):297-299
    [37]裴月湖,李铣,朱延儒,等.仙鹤草根芽中新二氢黄酮醇甙的结构研究.药学学报,1990,25(4):267-270
    [38]李霞,叶敏,余修祥,等.仙鹤草化学成分的研究.北京医科大学学报,1995,27(1):60-61
    [39]裴月湖,李铣,朱延儒.仙鹤草中新异香豆精甙的结构研究.药学学报,1989,24(11):837-840.
    [40]刘磊,王慧RP-HPLC法测定仙鹤草药材中槲皮素的含量.齐齐哈尔医学院学报.2009,30(11):1369-1370
    [41]Shizuo kasa, i Sayaka watanabe, Jun kawabata. Antimicrobialcatechin derivatives of agrimo niapilosa. Phytochemistry,1992,31(3):787-789
    [42]裴月湖,李铣,朱延儒.仙鹤草根芽中新鞣花酸甙的结构研究.药学学报,1990,25(10):798-800
    [43]孙磊,贾俊梅,李秀珍.仙鹤草微量元素的测定分析.微量元素与健康研究,2000,17(2):42-43
    [44]赵莹,赵春芳,刘金平,等.仙鹤草化学成分及其生物活性的研究.特产研究,2007,2:57-61
    [45]李雅文,黄兰芳,梁晟,等.仙鹤草挥发油化学成分的气相色谱—质谱分析.中南大学学报(自然科学版),2007,38(3):502-506
    [46]潘娅,刘红霞,庄玉磊,等.仙鹤草中黄酮类化学成分研究.中国中药杂志,2008,33(24):2925-2927
    [47]张健泓,陈优生.仙鹤草降糖活性成分研究.中药材,2009,32(10):1537-1539
    [48]高凯民,周玲,陈金英,等.仙鹤草煎剂对HL-60细胞的体外诱导凋亡作用.中药材,2000,23(9):561-562
    [49]谢沛珊,李爱媛,周芳,等.中草药抗肿瘤筛选的实验研究.时珍国药研究,1996,7(1):19
    [50]吴琳华,郭劲柏,刘红梅,等.仙鹤草注射液对人癌细胞生长抑制作用的研究.中国 中医药科技,2005,12(5):297-298
    [51]温雅,毕蕾,张义彪,等.仙鹤草水提液对肺癌A549细胞增殖的抑制作用.中医药信息,2009,26(5):33-35
    [52]袁静,王元勋,侯正明,等.仙鹤草鞣酸体外对人体肿瘤细胞的抑制作用.中国中医药科技,2000,7(6):378-379
    [53]郭炜,赵泽贞,单保恩,等.六种中草药抗突变及抗肿瘤活性的实验报告.癌变·畸变·突变,2002,14(2):94-98
    [54]李玉祥,樊华,张劲松,等.中草药抗癌的体外试验.中国医科大学学报,1999,30(1):37-42
    [55]王思功,李予蓉,王瑞宁,等.仙鹤草对人癌细胞裸鼠移植瘤的影响.第四军医大学学报,1998,19(6):702-704
    [56]马丽萍,赵培荣,王留兴,等.仙鹤草水提液对食管癌Eca109细胞生长的抑制作用.郑州大学学报(医学版),2007,42(1):149-151
    [57]王力倩,余上才,李仪奎,等.用血清药理学方法研究中药苦参、仙鹤草的抗肿瘤作用.中国中医药科技,1995,2(5):19
    [58]范尚坦,李金兰,姚振华.仙鹤草降血糖的实验研究.医药导报,2004,23(10):710-711
    [59]王思功,李予蓉,王瑞宁,等.仙鹤草颗粒对小鼠血糖的影响.第四军医大学学报,1999,20(7):640-642
    [60]万波,吴莹,曾英彤.仙鹤草降糖有效部位筛选研究.现代食品与药品杂志,2007,17(6):15-17
    [61]曹勇,骆永珍.仙鹤草对荷瘤小鼠IL-2活性影响的研究.中国中医药科技,1999,6(4):242
    [62]王德才,高允生,朱玉云,等.仙鹤草提取物对兔血压的影响.中国中医药信息杂志,2003,10(3):21-24
    [63]王德才,高允生,朱玉云,等.龙芽草乙醇提取物对兔血压和心率影响的实验研究.泰山医学院学报,2008,24(4):319-321
    [64]尤纪青,乐文菊,梅静艳.仙鹤草酚对体外培养的日本血吸虫的影响.药学学报,1982,17(9):663-663
    [65]柴桂珍,李广华,郭迎喜.补骨脂、仙鹤草对猪囊尾蚴作用的体外实验.中医药学报,1991,3:52
    [66]顾丽贞,张百舜,张润珍.仙鹤草对家兔体外血栓形成的抑制作用.中国中医药科技,1995,2(2):21
    [67]王德才,高允生,李珂,等.仙鹤草乙醇提取物抗炎镇痛作用的实验研究.泰山医学院学报,2004,25(1):7-8
    [68]龚纯贵,张国庆,王希营,等.仙鹤草提取物镇痛抗炎试验的实验研究.药学实践杂 志,2006,24(6):339-342
    [69]祝连彩,王伯初,谭君,等.仙鹤草醇提物及其不同极性部位的抗氧化活性研究.中药材,2009,32(8):1272-1275
    [70]杜文娟,仙鹤草应用.中国医药指南,2008,6(22):1872
    [71]杨学信.中西医结合治疗原发性血小板减少性紫癜86例疗效观察.新中医,2003,35(3):49-50
    [72]杨玉兰.增板汤治疗慢性特发性血小板减少性紫癜250例.陕西中医,2000,21(3):101-102
    [73师建国,刘茂君.紫草汤治疗小儿过敏性紫癜52例.陕西中医,2002,23(11):998
    [74]孔平孝,彭轶侠,文汉英,等.山仙颗粒治疗恶性肿瘤56.陕西中医,2002,23(9):778-779
    [75]孙大兴,裘维焰,赵树珍.肺康方治疗中晚期非小细胞肺癌疗效分析.中医药学报,2002,30(2):49-50
    [76]郭登洲,谢惠芬,王彦刚,等.肾炎宁治疗小儿IgA肾病25例疗效观察.新中医,2003,35(4):16-17
    [77]朱玮华,陈伟平.四草二根汤治疗小儿急性肾炎临床观察.北京中医药大学学报,2000,23(3):64-65
    [78]田耘,史健,于小勇.中药凉血止血药配合西药治疗IgA肾病42例.陕西中医,2004,25(4):303-304
    [79]冯怀新,陆德海,段景文,等.中药气流弥散结肠给药治疗溃疡性结肠炎60例.陕西中医,2000,21(1):1-2
    [80]周嘉莅,陈景平.咳喘平煎剂治疗小儿肺炎60例.陕西中医,2003,24(6):484-485
    [81]殷养国.仙百止咳汤治疗难治性咳嗽46例.陕西中医,2003,24(4): 302-303
    [82]李丽斌,富靖,陈秀荣.鲜仙鹤草治疗滴虫性阴道炎.时珍国药研究,1997,8(1):11
    [83]万来学,胡文宝.仙鹤草治疗内耳性眩晕.山东中医杂志,1995,14(2):89-89
    [84]许秀荣,许秀芬.仙鹤草治疗美尼尔氏综合征35例报告.山东医药,2002,42(21):68-69
    [85]张亚平,马琼.大剂量仙鹤草治疗梅尼埃病100例疗效观察.西部医学,2007,19(4):642-643
    [86]范尚坦,李金兰,杨忠东,等.单味仙鹤草治疗糖尿病1例.福建中医药,2002,33(2):32-33
    [87]陈国和.鸡蛋煎独活和仙鹤草及合用654-2片治疗眩晕症50例观察.河北医学,2005,11(7):593-594
    [88]赖中福,卢壬丹.过量服用木通、仙鹤草致肾功能衰竭各1例.中国药业,2003, 12(7):59
    [89]范尚坦,李金兰,左晖.仙鹤草的不良反应.福建中医药,2002,33(1): 47-48
    [90]赵明君,张翠英,张治祥,等.仙桂胶囊治疗低血压病50例.陕西中医,2005,26(8):777-778
    [91]冯卫生,减新钰,郑晓珂.鞣质的研进展究.中国新药杂志,2009,18(14):1308-1311
    [92]匡海学主编.中药化学.第1版.北京:中国中医药出版社,2003:366-377
    [93]胡小刚,李继革,郭书好,等.鞣质分析研究进展,中成药,2002,24(3):217-220
    [94]闫滨,张秋红,刘秀芳.植物中鞣质类化合物的化学研究进展.山东医药工业,2003,22(1):34-36
    [95]刘延泽,翼春茹.高效液相色谱法在中草药鞣质类研究中的应用.中草药,1991,22(2):89-91
    [96]徐勤.鞣质的研究进展.华夏医学,2008,17(1):113-115
    [97]杨林,周本宏.石榴皮中鞣质和黄酮类化合物抑菌作用的实验研究.时珍国医国药,2007,18(10):2335-2336
    [98]周本宏,刘春,陈雷,等.石榴皮中鞣质各组分对淋球菌敏感性的研究.时珍国医国药,2006,41(19):1510
    [99]金哲雄,齐典.刺玫果鞣质预防肿瘤作用研究.中华中医药学刊,2007,25(4):647-648
    [100]曾伟成,蔡钦榕,杨辉,等.虎杖鞣质抗脂质过氧化作用研究.中药药理与临床,2002,18(6):18-19
    [101]沈忠明,殷建伟,袁海波.虎杖鞣质的虎杖鞣质的降血糖作用研究.天然产物研究与开发,2004,16(3):220-221
    [102]王丽敏,卢春凤,路雅真,等.老鹳草鞣质类化合物的抗腹泻作用研究.黑龙江医药科学,2003,26(5):28-29
    [103]吕晓东,杨胜,齐春会,等.山茱萸鞣质活性部位对佐剂性关节炎大鼠免疫功能的影响.中国农业大学学报,2008,35(69):1023-1026
    [104]张军峰,谭健,蒲蔷,等.青蒿鞣质抗病毒活性研究.天然产物研究与开发,2004,16(4):307-310
    [105]张军峰,郑鸿燕,谭健,等.青蒿鞣质抗单纯疱疹病毒机理初探.江苏药学与临床研究,2009,13(1):11-14
    [106]姚思宇,赵鹏,刘荣珍,等.鞣质降血脂作用的动物实验研究.中国热带医学,2004,4(6):945-946
    [107]杨林,周本宏,冯琪,等.石榴皮鞣质降低尿毒素作用的研究.中国药房,2007,18(30):2345-2347
    [108]呙爱秀,黄兴国,唐湘云.余甘子中水溶性鞣质的抗动脉粥样硬化作用机制研究.实用预防医学,2008,14(2):352-355
    [109]金在久.仙鹤草的化学成分及临床研究进展.华西药学杂志,2006,21(5):468-471
    [110]董庆武.仙鹤草的化学成分与应用.人参研究.2009,4:43
    [111]冯卫生.鞣质类化合物的生物活性研究进展.中国医药情报,1996,2(4):220
    [112]王宗伟.植物鞣质的药理作用及结构特征.国外医学中医中药分册,1997,19(2):22
    [113]石碧,狄荧.鞣质的药理活性.中草药,1998,29(7):487
    [114]吴谦,金哲雄.药用植物中鞣质的生理活性.黑龙江医药,1995,8(4):236
    [115]陈晓光,韩锐.鞣质与癌的化学预防.实用肿瘤杂志,1995,10(2):121-124
    [116]孙素琴,秦竹,周群,等.中药药材红外光谱非分离提取多级宏观指纹鉴定方法.中国专利:CN 147110A.2003
    [117]孙素琴,周群,秦竹.中药二维相关红外光谱鉴定图集.北京:化学工业出版社,2003.9
    [118]刘岩,刘顺航,王俊全,等.红外光谱应用新进展及其与色谱指纹图谱对比分析.光谱学与光谱分析,2007,27(6):1093-1097
    [119]中华人民共和国国家药典委员会编.中华人民共和国药典.北京:化学工业出版社,2004
    [120]韩明霞,周群,李全宏,等.不同产地葛根红外光谱的三级鉴定.光谱学与光谱分析,2009,28(7):1851-1854
    [121]孙素琴,周群,秦竹.中药二维相关红外光谱鉴定图集.北京:化学工业出版社,2003
    [122]郁露,孙素琴,周群,等.白芥子炒制过程的红外及二维相关光谱研究.光谱学与光谱分析,2006,26(12):2181-2185
    [123]吴婧,孙素琴,周群,等.丹参配方颗粒红外无损快速分析研究.2007,27(8):1535-1538
    [124]孙素琴,周群,郁鉴源.分子振动光谱法与中药研究的最新进展.光谱学与光谱分析,2000,20(2):199-201
    [125]阿依古丽.塔西,周群,董晓鸥,等.甘草真伪品的FTIR光谱法鉴别研究.光谱学与光谱分析,2006,26(7):1238-1241
    [126]邓月娥,孙素琴, 周群,等FTIR光谱法与燕窝的品质分析.光谱学与光谱分析,2006,26(7):1242-1245
    [127]聂波,张贵君,孙素琴,等.不同金莲花药材的IR鉴别研究.中药材,2006,29(4),323-326
    [128]周欣,孙素琴,黄庆华FTIR对不同产地陈皮的鉴别研究.光谱学与光谱分析,2007,29(20):2453-2455
    [129]郝朝运,程存归,刘鹏FTIR直接测定法在解决忍冬科一些分类学问题中的应用研究.光谱学与光谱分析,2007,27(1):38-42
    [130]武彦文’肖小河,孙素琴,等.黄连不同提取物的红外光谱研究.光谱学与光谱分析,2009,29(1):93-96
    [131]宋光志,刘静,谢道刚.五倍子鞣酸对照品的制备及质量标准研究.世界科学技术-中医药现代化,2004,6(6):63-66
    [132]罗素琴,刘乐乐,王建华等.蒙药协日汤散剂中鞣质含量测定.内蒙古科技与经济,2002,(3):125
    [133]陈燕,刘玉红,易进海等.二十五味大汤胶囊中鞣质的含量测定.中成药,2002,24(10):766-767
    [134]戴万生,赵荣华,陈红波.干酪素法测定大黄鞣质类成分的研究.时珍国医国药,2009,14(6):324-325
    [135]李志猛,李向日.干酪素法测定不同产地金樱子中鞣质类成分的研究.中华中医药杂志,2009,24(2):230-232
    [136]罗文毓,章育中.大黄中鞣质测定方法的研究Ⅰ干酪素法.药物分析杂志,1986,6(1):15-17
    [137]徐淑云,卞如廉,陈修.药理实验方法学.北京:人民卫生出版社,1982:1757-1767
    [138]杨静,马力文.肿瘤与机体抗氧化系统.肿瘤防治杂志,2004,11(3):324-327
    [139]林立,刘军,张凯,等.丙溴磷对家兔SOD、CAT、GSH-Px影响的实验研究.卫生研究,2008,32(5):434-435
    [140]吕峰,黄一帆,池淑芳,等.薏苡仁多糖对小鼠的抗氧化作用的研究.营养学报,2008,30(6):604-607
    [141]谭卫东,金红,罗弟祥,等.抗肿瘤药物筛选中MTT法和SRB法的比较.天然药物研究与开发,2009,11(3):17-21
    [142]姚静,李小兰,吴剑宏,等.抗肿瘤药物敏感性实验方法比较.中华实验外科杂志,2005,22(7):792-793
    [143]刘吉成,崔红霞,孙建宁.姬松茸多糖诱导Bel-7402细胞凋亡的实验研究.北京中医药大学学报,2006,29(6):408-411
    [144]许惠玉,徐广友,陈志伟,等.赤芍总苷诱导肿瘤细胞凋亡机制的研究.中医药学刊,2005,23(10):1798-1800
    [145]陈庆华.细胞凋亡机制的研究应用.广东畜牧兽医科技,2006,31(2):18-21
    [146]薛全福,王振纲.钙离子和细胞凋亡及药物调控.中国全科医学,2009,12(6B):1126-1128[147]梁枫,王明艳,许冬青.斑蝥酸钠诱导人胃腺癌BGC-823细胞凋亡的实验研究.南京中医药大学学报,2006,22(3):171-172[148]王莉,常彦忠,段相林.铁离子对Caco-2细胞内钙离子转运的影响及钙离子浓度 变化与细胞凋亡关系的研究.解剖学报,2005,36(2):177-181
    [149]季宇彬,高世勇.羊栖菜多糖体外抗肿瘤作用及其作用机制的研究.中草药,2003,34(12):1111-1114
    [150]闫华超,李林尉.抗肿瘤药物诱导肿瘤细胞凋亡机制的研究进展.聊城大学学报(自然科学版),2009,22(3):42-47
    [151]季宇彬,何相晶,曲中原,等.活性氧诱导细胞凋亡的研究进展.中草药,2009,40:19-21

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700